CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 158 enrolled
Drug / intervention
Lyophilized Fecal Microbiota Transplantationdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03834038
NCT03834038N/ACompleted
CompareCT.gov

Prospective, Open-label Trial to Evaluate Efficacy of Lyophilized Fecal Microbiota Transplantation for Treatment of Recurrent C. Difficile Infection

Vancouver Island Health Authority·interventional·Posted Feb 7, 2019·Updated Sep 23, 2024

In Brief

A clinical study evaluating Lyophilized Fecal Microbiota Transplantation for Recurrent Clostridium Difficile Infection. Completed, enrolled 158 participants across 1 site.

Detailed Summary

The primary goal is to study participants with recurrent C. difficile infection (CDI) treated with lyophilized fecal microbiota transplantation (FMT). The safety, clinical response and relapse rate in patients will be assessed.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRecurrent Clostridium Difficile Infection
CountriesCanada
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedFeb 7, 2019
Enrollment StartOct 1, 2015
Primary CompletionMar 1, 2018
Study CompletionMar 17, 2020
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 7.4 years ago

Interventions

Lyophilized Fecal Microbiota Transplantationdrug

Lyophilized FMT